| 13/05 | INSIDER SELL: Ocugen |  |
| 06/05 | OCUGEN, INC. Management's Discussion and Analysis of Financial Condition and Results
o.. | |
| 06/05 | TRANSCRIPT: Ocugen, Inc., Q1 2022 Earnings Call, May 06, 2022 | |
| 06/05 | Ocugen's Q1 Net Loss Widens | |
| 06/05 | OCUGEN, INC.: Results of Operations and Financial Condition, Other Events, Financial Stat.. | |
| 06/05 | Ocugen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 06/05 | OCUGEN: Q1 Earnings Snapshot | |
| 06/05 | Ocugen Provides Business Update and First Quarter 2022 Financial Results | |
| 02/05 | OCUGEN TO HOST CONFERENCE CALL ON FR: 30 a.m. ET to Provide Business Update and Discuss F.. | |
| 29/04 | Ocugen, Inc. to Present Preclinical Results at The Association for Research in Vision a.. | |
| 28/04 | Ocugen, Inc. Announces Manish Potti Will Not Stand for Re-Election as Class II Director | |
| 25/04 | Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial | |
| 25/04 | Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial | |
| 25/04 | Certain Common Stock of Ocugen, Inc. are subject to a Lock-Up Agreement Ending on 25-AP.. | |
| 25/04 | Certain Preferred Stock of Ocugen, Inc. are subject to a Lock-Up Agreement Ending on 25.. | |
| 25/04 | Certain Warrants of Ocugen, Inc. are subject to a Lock-Up Agreement Ending on 25-APR-20.. | |
| 25/04 | Certain Restricted Stock Units of Ocugen, Inc. are subject to a Lock-Up Agreement Endin.. | |
| 25/04 | Certain Stock Options of Ocugen, Inc. are subject to a Lock-Up Agreement Ending on 25-A.. | |
| 20/04 | OCUGEN, INC.: Other Events, Financial Statements and Exhibits (form 8-K) | |
| 19/04 | Ocugen, Inc. to Present at NobleCon18 | |
| 18/04 | OCUGEN, INC.: Entry into a Material Definitive Agreement (form 8-K) | |
| 18/04 | Ocugen, Inc. and Bharat Biotech International Limited Enters into Second Amendment to C.. | |
| 18/04 | Ocugen Obtains Commercialization Rights of Covaxin in Mexico | |
| 18/04 | Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of .. | |
| 12/04 | Ocugen's Study of COVID-19 Vaccine Put on Clinical Hold After Issues at Bharat Biotech .. | |
| 12/04 | OCUGEN: Provides Update on its Phase 2/3 Study of COVAXIN™ (BBV152) - Form 8-K | |
| 12/04 | OCUGEN, INC.: Other Events, Financial Statements and Exhibits (form 8-K) | |
| 12/04 | Ocugen, Inc. Provides Update on its Phase 2/3 Study of COVAXIN™ (BBV152) | |
| 12/04 | Ocugen, Inc. Provides Update on its Phase 2/3 Study of COVAXIN™ | |
| 12/04 | OCUGEN: FDA Has Placed Co.'s Covid Vaccine Trial on Clinical Hold | |
| 04/04 | OCUGEN, INC.: Other Events, Financial Statements and Exhibits (form 8-K) | |
| 01/04 | Ocugen Doses First Patient in Phase 1/2 Trial of Gene Therapy to Treat Retinal Degenera.. | |
| 01/04 | Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial for Gene Therapy.. | |
| 01/04 | Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial for Gene Therapy.. | |
| 23/03 | OCUGEN, INC.: Change in Directors or Principal Officers (form 8-K) | |
| 23/03 | Ocugen Announces Appointment of Marna C. Whittington, PhD, to Board of Directors | |
| 23/03 | Ocugen, Inc. Announces Board Changes | |
| 22/03 | Ocugen Promotes Jessica Crespo to Chief Accounting Officer | |
| 21/03 | Ocugen, Inc. Appoints Jessica Crespo, CPA, to Chief Accounting Officer and Senior Vice .. | |
| 21/03 | Ocugen, Inc. Appoints Jessica Crespo as Chief Accounting Officer and Senior Vice Presid.. | |
| 18/03 | Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| 11/03 | OCUGEN, INC.: Other Events, Financial Statements and Exhibits (form 8-K) | |
| 09/03 | Ocugen, Inc. to Present at the 34th Annual ROTH Conference | |
| 08/03 | Inozyme Pharma Appoints Former Ocugen Finance Chief Sanjay Subramanian in Same Role | |
| 07/03 | Ocugen Provides an Update on its COVAXIN Pediatric (2-18) Emergency Use Authorization (.. | |
| 04/03 | OCUGEN: Provides an Update on its COVAXIN™ Pediatric (2-18) Emergency Use Authoriza.. | |
| 04/03 | OCUGEN, INC.: Change in Directors or Principal Officers, Other Events, Financial Statemen.. | |
| 04/03 | Ocugen, Inc. Announces Resignation of Sanjay S. Subramanian as Chief Financial Officer | |
| 04/03 | Ocugen, Inc. Announces Executive Changes | |
| 04/03 | SECTOR UPDATE: Health Care Investors Squaring Positions Ahead of Weekend Break | |
| 04/03 | SECTOR UPDATE: Health Care Stocks Recovering This Afternoon | |
| 04/03 | Ocugen Shares Hit 52-Week Low After FDA Declines EUA for Covaxin | |
| 04/03 | SECTOR UPDATE: Health Care Stocks Retreat Pre-Bell Friday | |
| 04/03 | Wall Street Set for Downbeat Session as Ukraine Crisis Deepens, Strong US Jobs Report C.. | |
| 04/03 | SECTOR UPDATE: Health Care | |
| 04/03 | Top Premarket Decliners | |
| 04/03 | Ocugen Says FDA Rejects Emergency Use Authorization For Covaxin COVID Vaccine Candidate.. | |
| 04/03 | OCUGEN: FDA Declines EUA for Covid-19 Vaccine in Ages 2 to 18 | |
| 04/03 | Ocugen Provides an Update on its COVAXIN™ Pediatric (2-18) Emergency Use Authoriz.. | |
| 04/03 | Ocugen, Inc. Provides Update on its COVAXIN™ Pediatric (2-18) Emergency Use Author.. | |
| 28/02 | Ocugen Provides Business Update With Fourth Quarter and Full Year 2021 Financial Result.. | |
| 28/02 | OCUGEN, INC. Management's Discussion and Analysis of Financial Condition and Results
o.. | |
| 28/02 | Ocugen, Inc. Auditor Raises 'Going Concern' Doubt | |
| 25/02 | SECTOR UPDATE: Health Care Stocks Mixed Pre-Bell Friday | |
| 25/02 | TRANSCRIPT: Ocugen, Inc., Q4 2021 Earnings Call, Feb 25, 2022 | |
| 25/02 | Ocugen Posts Wider Q4 Net Loss | |
| 25/02 | OCUGEN: Provides Business Update With Fourth Quarter and Full Year 2021 Financial Results.. | |
| 25/02 | OCUGEN: Q4 Earnings Snapshot | |
| 25/02 | Ocugen, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended Decemb.. | |
| 25/02 | OCUGEN, INC.: Entry into a Material Definitive Agreement, Financial Statements and Exhibi.. | |
| 25/02 | Ocugen Provides Business Update With Fourth Quarter and Full Year 2021 Financial Result.. | |
| 23/02 | SECTOR UPDATE: Health Care Stocks Unable to Retain Midday Rise | |
| 23/02 | Ocugen Prices $53.5 Million Common Stock Offering; Shares Sink | |
| 23/02 | SECTOR UPDATE: Health Care Stocks Higher in Wednesday Trading | |
| 23/02 | Ocugen Prices $53.5 Million Common Stock Offering | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
